Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas
- Conditions
- B-cell Non-Hodgkin LymphomasAdvanced Solid Tumors
- Interventions
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2025-06-09
- Lead Sponsor
- Antengene Biologics Limited
- Target Recruit Count
- 80
- Registration Number
- NCT06028373
- Locations
- 🇺🇸
University of California San Francisco (UCSF), San Francisco, California, United States
🇺🇸Regents of the University of Colorado, Aurora, Colorado, United States
🇺🇸Yale University, New Haven, Connecticut, United States
A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Antengene Biologics Limited
- Target Recruit Count
- 156
- Registration Number
- NCT05718895
- Locations
- 🇨🇳
Fujian Cancer Hospital, Fuzhou, China
🇨🇳Jinan Central Hospital, Jinan, China
🇨🇳Fudan University Shanghai Cancer Center, Shanghai, China
A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas
- Conditions
- Advanced Solid TumorMetastatic Solid TumorMature B-cell Non-Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2025-06-09
- Lead Sponsor
- Antengene Biologics Limited
- Target Recruit Count
- 31
- Registration Number
- NCT04986865
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States